Skip to main content
Premium Trial:

Request an Annual Quote

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

Researchers reporting in Molecular Systems Biology describe the role of peroxiredoxin 1 (PRDX1) in DNA damage repair. The researchers from Spain, Austria, and the US examined how metabolic factors affect DNA damage response in cell lines using a combination of CRISPR-Cas9 functional genetic screens, chromatin proteomics, and targeted metabolomics. After applying the damage-inducing chemotherapeutic etoposide to the cell lines, the researchers noted an increase in nuclear reactive oxygen species (ROS) and a shifting of cellular respiratory enzymes from mitochondria to the damaged site. In particular, PRDX1, an antioxidant enzyme generally found in mitochondria, accumulates in the nucleus where it scavenges ROS. The researchers further found that PRDX1 regulates the availability of aspartate, which is needed for nucleotide synthesis. "Our study sheds light on the interplay between cellular metabolism and the DNA damage response," the researchers write. "This is particularly relevant in cancer, which can be considered both a metabolic and a genetic disease, thus better understanding of this crosstalk better could help design more efficient and targeted therapies."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.